Munar Pharma (MUN.WA) Stock Price

Munar Pharma Price

CLOSED
0.39
​
Market closed

Revenue at Munar Pharma has contracted by 11.4% per year over the past 9 years to 250,900.00 PLN. For Munar Pharma, the net margin of 45.8% is up versus -67.1% a few years ago.

Munar Pharma stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Munar Pharma business model & stock analysis

No Gravity Games SA generates revenue by providing internet-related services, including content management systems, web shops, and website implementation. The company leverages its own technical infrastructure and programming resources to create and maintain specialized websites for its corporate clients. These digital assets include audiostereo.pl for audio enthusiasts, zagraj.com.pl as an online games portal, and legalneinfo.pl, which serves as an online catalogue of free software. The firm further supports application development and external software development for its corporate clients. Its portfolio extends to sport1.pl, offering information on disciplines such as football, volleyball, basketball, tennis, handball, and winter sports. Additional sites managed by the company include YOYO.pl, an independent provider of free hosting services, as well as chillisport.pl, oboe.pl, legenhit.pl, webtips.pl, xt.pl, and websonda.pl.

Frequently asked questions about Munar Pharma

Converted at the current exchange rate, the Munar Pharma share trades at 0.09 EUR (0.39 PLN).

The revenue cannot currently be calculated for Munar Pharma.

The profit cannot currently be calculated for Munar Pharma.

The P/E ratio cannot be calculated for Munar Pharma at the moment.

The P/S cannot be calculated for Munar Pharma currently.

The Eulerpool Quality Score for Munar Pharma is 3/10.

The ISIN of Munar Pharma is PLSITE000013. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Munar Pharma is A1J15E. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Munar Pharma is MUN.WA. The ticker symbol is used to trade Munar Pharma shares on the stock exchange.

Fair ValueTerminal
0.32 PLN
Over-/UndervaluationTerminal
Fairly valued
Industry
Entertainment
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Poland
Currency
PLN
Initial public offering
Jun 18, 2010
ISIN
PLSITE000013
Cusip
X7860R108
Market capitalization
18.32 M PLNMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/Se
—
EV/EBIT
—
P/B Ratio
8.14
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-18.39 %
Last updated Nov 20, 2026, 6:12 PM

Munar Pharma Peer Group

Munar Pharma FIGI

NGG:PW · BBG000R21HR7FDGPLN:XS · BBG00PPYT796FDGPLN:XH · BBG00PPYT7D1FDGPLN:XF · BBG00PPYT7G8FDGPLN:XD · BBG00PPYT7H7FDGPLN:XE · BBG00PPYT7J5FDGPLN:XJ · BBG00PPYT7K3FDGPLN:XL · BBG00PPYT7L2FDGPLN:XG · BBG00PPYT7M1FDGPLN:XO · BBG00PPYT7N0FDGPLN:XN · BBG00PPYT7P8FDGPLN:XA · BBG00PPYT7S5

All fundamentals and in-depth analysis of Munar Pharma

Our stock analysis for Munar Pharma stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Munar Pharma. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.